Research Catalog

Medical isotope production without highly enriched uranium

Title
Medical isotope production without highly enriched uranium / Committee on Medical Isotope Production Without Highly Enriched Uranium, Nuclear and Radiation Studies Board, Division of Earth and Life Studies, National Research Council of the National Academies.
Author
National Research Council (U.S.). Committee on Medical Isotope Production Without Highly Enriched Uranium.
Publication
Washington, D.C. : National Academies Press, [2009], ©2009.

Items in the Library & Off-site

Filter by

1 Item

StatusFormatAccessCall NumberItem Location
TextRequest in advance QD181.U7 N385 2009gOff-site

Holdings

Details

Description
xviii, 202 pages : illustrations (some color); 23 cm
Summary
"This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply."
Subject
  • Molybdenum > supply & distribution
  • Technetium > supply & distribution
  • Nuclear Reactors > economics
  • Nuclear Reactors > legislation & jurisprudence
  • Radioisotopes > supply & distribution
  • Uranium
  • Uranium > Therapeutic use
  • Highly enriched uranium > Therapeutic use
  • Molybdenum > Therapeutic use
  • Technetium > Therapeutic use
  • Radioisotopes > Therapeutic use
  • Nuclear medicine > Standards > United States
  • United States
Bibliography (note)
  • Includes bibliographical references.
Additional Formats (note)
  • Also available in Open Book format via the National Academies Press home page.
Contents
Background and study task -- Molybdenum-99/Technetium-99m production and use -- Molybdenum-99/Technetium-99m supply -- Molybdenum-99/Technetium-99m supply reliability -- Molybdenum-99/Technetium-99m demand -- Molybdenum-99/Technetium-99m production costs -- Conversion to LEU-based production of Molybdenum-99: technical considerations -- Conversion to LEU-based production of Molybdenum-99: regulatory considerations -- Conversion to LEU-based production of Molybdenum-99: general approaches and timing -- Conversion to LEU-based production of Molybdenum-99: prospects and feasibility.
ISBN
  • 9780309130394 (pbk.)
  • 0309130395 (pbk.)
OCLC
  • 310392635
  • ocn310392635
  • SCSB-5476529
Owning Institutions
Columbia University Libraries